Cargando…

Anti-Brucella activity of Caryopteris mongolica Bunge root extract against Brucella melitensis infection in mice

BACKGROUND: The current treatment for human brucellosis requires a combination of antibiotics for long periods of time, and the reported incidence and prevalence of the disease vary widely in nomadic livestock of Mongolia. The objective of the present study was to evaluate the in vivo antibacterial...

Descripción completa

Detalles Bibliográficos
Autores principales: N, Tsevelmaa, B, Narangerel, O, Odgerel, D, Dariimaa, J, Batkhuu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5934838/
https://www.ncbi.nlm.nih.gov/pubmed/29724202
http://dx.doi.org/10.1186/s12906-018-2220-y
_version_ 1783320189500129280
author N, Tsevelmaa
B, Narangerel
O, Odgerel
D, Dariimaa
J, Batkhuu
author_facet N, Tsevelmaa
B, Narangerel
O, Odgerel
D, Dariimaa
J, Batkhuu
author_sort N, Tsevelmaa
collection PubMed
description BACKGROUND: The current treatment for human brucellosis requires a combination of antibiotics for long periods of time, and the reported incidence and prevalence of the disease vary widely in nomadic livestock of Mongolia. The objective of the present study was to evaluate the in vivo antibacterial activity of the C. mongolica root extract against B. melitensis. METHODS: In this study, we used of 6 groups of mice (n = 5). Five groups of BALB/c mice were inoculated intraperitoneally with the M16 strain of B. melintensis, as follows: (i) one group was used for pretreatment monitoring; (ii) the control group was administered 2% Tween 80 and was used as the non-treatment group; and the other three groups were treated with one oral gavage per day for 21 days with (iii) doxycycline (2 mg/day), (iv) doxycycline (1 mg/day) with root extract (20 mg/day), and (v) C. mongolica root extract (20 mg/day). The one group that was kept non-infected was used as a healthy control group. RESULTS: This study demonstrated that daily treatment with doxycycline alone and in combination with C. mongolica root extract significantly reduced splenic infection at the end of treatment. However, the spleen index of both the doxycycline-treated and the combination-treated groups of mice decreased by approximately 50% compared to that of the healthy control mouse group. Treatment with the C. mongolica root extract resulted in a 1.47log reduction in splenic infection compared to the non-treatment group, and the spleen index of the C. mongolica-treated group of mice was the same as that of the normal mouse group. In all treatment groups, neutrophil phagocytic activity significantly decreased, and all treatment groups demonstrated splenic regeneration. CONCLUSIONS: The present study showed that the C. mongolica root extract may be useful in the treatment of brucellosis patients, in combination with doxycycline or other antibiotics, to reduce the toxicity of high-dosage antibiotics, to prevent the development of antibiotic resistance and to prevent Brucella infection.
format Online
Article
Text
id pubmed-5934838
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-59348382018-05-11 Anti-Brucella activity of Caryopteris mongolica Bunge root extract against Brucella melitensis infection in mice N, Tsevelmaa B, Narangerel O, Odgerel D, Dariimaa J, Batkhuu BMC Complement Altern Med Research Article BACKGROUND: The current treatment for human brucellosis requires a combination of antibiotics for long periods of time, and the reported incidence and prevalence of the disease vary widely in nomadic livestock of Mongolia. The objective of the present study was to evaluate the in vivo antibacterial activity of the C. mongolica root extract against B. melitensis. METHODS: In this study, we used of 6 groups of mice (n = 5). Five groups of BALB/c mice were inoculated intraperitoneally with the M16 strain of B. melintensis, as follows: (i) one group was used for pretreatment monitoring; (ii) the control group was administered 2% Tween 80 and was used as the non-treatment group; and the other three groups were treated with one oral gavage per day for 21 days with (iii) doxycycline (2 mg/day), (iv) doxycycline (1 mg/day) with root extract (20 mg/day), and (v) C. mongolica root extract (20 mg/day). The one group that was kept non-infected was used as a healthy control group. RESULTS: This study demonstrated that daily treatment with doxycycline alone and in combination with C. mongolica root extract significantly reduced splenic infection at the end of treatment. However, the spleen index of both the doxycycline-treated and the combination-treated groups of mice decreased by approximately 50% compared to that of the healthy control mouse group. Treatment with the C. mongolica root extract resulted in a 1.47log reduction in splenic infection compared to the non-treatment group, and the spleen index of the C. mongolica-treated group of mice was the same as that of the normal mouse group. In all treatment groups, neutrophil phagocytic activity significantly decreased, and all treatment groups demonstrated splenic regeneration. CONCLUSIONS: The present study showed that the C. mongolica root extract may be useful in the treatment of brucellosis patients, in combination with doxycycline or other antibiotics, to reduce the toxicity of high-dosage antibiotics, to prevent the development of antibiotic resistance and to prevent Brucella infection. BioMed Central 2018-05-03 /pmc/articles/PMC5934838/ /pubmed/29724202 http://dx.doi.org/10.1186/s12906-018-2220-y Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
N, Tsevelmaa
B, Narangerel
O, Odgerel
D, Dariimaa
J, Batkhuu
Anti-Brucella activity of Caryopteris mongolica Bunge root extract against Brucella melitensis infection in mice
title Anti-Brucella activity of Caryopteris mongolica Bunge root extract against Brucella melitensis infection in mice
title_full Anti-Brucella activity of Caryopteris mongolica Bunge root extract against Brucella melitensis infection in mice
title_fullStr Anti-Brucella activity of Caryopteris mongolica Bunge root extract against Brucella melitensis infection in mice
title_full_unstemmed Anti-Brucella activity of Caryopteris mongolica Bunge root extract against Brucella melitensis infection in mice
title_short Anti-Brucella activity of Caryopteris mongolica Bunge root extract against Brucella melitensis infection in mice
title_sort anti-brucella activity of caryopteris mongolica bunge root extract against brucella melitensis infection in mice
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5934838/
https://www.ncbi.nlm.nih.gov/pubmed/29724202
http://dx.doi.org/10.1186/s12906-018-2220-y
work_keys_str_mv AT ntsevelmaa antibrucellaactivityofcaryopterismongolicabungerootextractagainstbrucellamelitensisinfectioninmice
AT bnarangerel antibrucellaactivityofcaryopterismongolicabungerootextractagainstbrucellamelitensisinfectioninmice
AT oodgerel antibrucellaactivityofcaryopterismongolicabungerootextractagainstbrucellamelitensisinfectioninmice
AT ddariimaa antibrucellaactivityofcaryopterismongolicabungerootextractagainstbrucellamelitensisinfectioninmice
AT jbatkhuu antibrucellaactivityofcaryopterismongolicabungerootextractagainstbrucellamelitensisinfectioninmice